BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29907525)

  • 1. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.
    Halim TYF; Rana BMJ; Walker JA; Kerscher B; Knolle MD; Jolin HE; Serrao EM; Haim-Vilmovsky L; Teichmann SA; Rodewald HR; Botto M; Vyse TJ; Fallon PG; Li Z; Withers DR; McKenzie ANJ
    Immunity; 2018 Jun; 48(6):1195-1207.e6. PubMed ID: 29907525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T helper cell IL-4 drives intestinal Th2 priming to oral peanut antigen, under the control of OX40L and independent of innate-like lymphocytes.
    Chu DK; Mohammed-Ali Z; Jiménez-Saiz R; Walker TD; Goncharova S; Llop-Guevara A; Kong J; Gordon ME; Barra NG; Gillgrass AE; Van Seggelen H; Khan WI; Ashkar AA; Bramson JL; Humbles AA; Kolbeck R; Waserman S; Jordana M
    Mucosal Immunol; 2014 Nov; 7(6):1395-404. PubMed ID: 24781052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
    Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
    J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33-ILC2 axis promotes anti-tumor CD8
    Okuyama Y; Okajima A; Sakamoto N; Hashimoto A; Tanabe R; Kawajiri A; Kawabe T; Ishii N
    Biochem Biophys Res Commun; 2022 Dec; 637():9-16. PubMed ID: 36375254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.
    Foks AC; van Puijvelde GH; Bot I; ter Borg MN; Habets KL; Johnson JL; Yagita H; van Berkel TJ; Kuiper J
    J Immunol; 2013 Nov; 191(9):4573-80. PubMed ID: 24068673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis.
    Karulf M; Kelly A; Weinberg AD; Gold JA
    J Immunol; 2010 Oct; 185(8):4856-62. PubMed ID: 20844189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.
    Oliphant CJ; Hwang YY; Walker JA; Salimi M; Wong SH; Brewer JM; Englezakis A; Barlow JL; Hams E; Scanlon ST; Ogg GS; Fallon PG; McKenzie AN
    Immunity; 2014 Aug; 41(2):283-95. PubMed ID: 25088770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus.
    Ekkens MJ; Liu Z; Liu Q; Whitmire J; Xiao S; Foster A; Pesce J; VanNoy J; Sharpe AH; Urban JF; Gause WC
    J Immunol; 2003 Jan; 170(1):384-93. PubMed ID: 12496423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo.
    Jenkins SJ; Perona-Wright G; Worsley AG; Ishii N; MacDonald AS
    J Immunol; 2007 Sep; 179(6):3515-23. PubMed ID: 17785785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of OX40/OX40L in ILC2-mediated activation of CD4
    Wu J; Cui Y; Zhu W; Bai S; Zhao N; Liu B
    Int Immunopharmacol; 2019 Nov; 76():105784. PubMed ID: 31470268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures.
    Gold MJ; Antignano F; Halim TY; Hirota JA; Blanchet MR; Zaph C; Takei F; McNagny KM
    J Allergy Clin Immunol; 2014 Apr; 133(4):1142-8. PubMed ID: 24679471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
    Symowski C; Voehringer D
    Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation.
    Di C; Lin X; Zhang Y; Zhong W; Yuan Y; Zhou T; Liu J; Xia Z
    J Biol Chem; 2015 May; 290(20):12523-36. PubMed ID: 25839234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helminth-conditioned dendritic cells prime CD4+ T cells to IL-4 production in vivo.
    Connor LM; Tang SC; Camberis M; Le Gros G; Ronchese F
    J Immunol; 2014 Sep; 193(6):2709-17. PubMed ID: 25108019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches.
    Dahlgren MW; Jones SW; Cautivo KM; Dubinin A; Ortiz-Carpena JF; Farhat S; Yu KS; Lee K; Wang C; Molofsky AV; Tward AD; Krummel MF; Peng T; Molofsky AB
    Immunity; 2019 Mar; 50(3):707-722.e6. PubMed ID: 30824323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control.
    Schwartz C; Khan AR; Floudas A; Saunders SP; Hams E; Rodewald HR; McKenzie ANJ; Fallon PG
    J Exp Med; 2017 Sep; 214(9):2507-2521. PubMed ID: 28747424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
    Drake LY; Iijima K; Kita H
    Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between ILC2s and Th2 cells varies among mouse models.
    Gurram RK; Wei D; Yu Q; Butcher MJ; Chen X; Cui K; Hu G; Zheng M; Zhu X; Oh J; Sun B; Urban JF; Zhao K; Leonard WJ; Zhu J
    Cell Rep; 2023 Feb; 42(2):112073. PubMed ID: 36735533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of type 2 innate lymphoid cells and T
    De Grove KC; Provoost S; Hendriks RW; McKenzie ANJ; Seys LJM; Kumar S; Maes T; Brusselle GG; Joos GF
    J Allergy Clin Immunol; 2017 Jan; 139(1):246-257.e4. PubMed ID: 27315767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.